• Female
  • 04/08/1992
  • Followed by 5 people
Recent Updates
  • mRNA therapeutics and Vaccines market Research Report by 2022, Forecast till 2035

    Characterized by a rapidly growing pipeline of products, the mRNA therapeutics and vaccines segment is anticipated to revolutionize the biopharmaceutical industry

    Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Therapeutics and mRNA Vaccines Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade.


    It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
     A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters.
     A detailed overview of the current market of players engaged in the development of mRNA therapeutics and vaccines.
     An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.
     Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and mRNA vaccines.
     A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021).
     An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters.
     An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters.
     An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry.
     A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022.
     An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

     Routes of Administration
     Intradermal
     Intravenous
     Intranasal
     Others

     Therapeutic Area
     Infectious Diseases
     Oncological Disorders
     Other Disorders

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Latin America
     Middle East and North Africa

    Key companies covered in the report
     Arcturus Therapeutics
     BioNTech and Pfizer
     CureVac
     Gennova
     Moderna
     Walvax


    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html

    You may also be interested in the following titles:
    Gene Switch Market

    Digital Biomanufacturing Market


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #mRNA therapeutics and Vaccines Market #mRNAtherapeuticsandVaccinesMarketGrowth #mrnavaccines #mrnabasedvaccines #mrnatherapeutics
    mRNA therapeutics and Vaccines market Research Report by 2022, Forecast till 2035 Characterized by a rapidly growing pipeline of products, the mRNA therapeutics and vaccines segment is anticipated to revolutionize the biopharmaceutical industry Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Therapeutics and mRNA Vaccines Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters.  A detailed overview of the current market of players engaged in the development of mRNA therapeutics and vaccines.  An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.  Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and mRNA vaccines.  A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021).  An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters.  An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters.  An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry.  A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022.  An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Routes of Administration  Intradermal  Intravenous  Intranasal  Others  Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa Key companies covered in the report  Arcturus Therapeutics  BioNTech and Pfizer  CureVac  Gennova  Moderna  Walvax To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html You may also be interested in the following titles: Gene Switch Market Digital Biomanufacturing Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mRNA therapeutics and Vaccines Market #mRNAtherapeuticsandVaccinesMarketGrowth #mrnavaccines #mrnabasedvaccines #mrnatherapeutics
    WWW.ROOTSANALYSIS.COM
    mRNA Therapeutics and mRNA Vaccines Market Size, Share, Trends and Forecast (2035)
    With over 35 players engaged in development of mRNA therapeutics and mRNA vaccines, and nearly USD 11 billion funding by investors, the market is anticipated to grow rapidly in the coming years
    0 Comments 0 Shares
  • Manufacturing execution systems market Research Report by 2022, Forecast till 2035

    Rising complexities related to huge data volumes being generated in the healthcare sector, along with the need for visibility, control and synchronization in production processes, has prompted players in the healthcare market to integrate manufacturing execution systems

    Driven by the ongoing innovation in the healthcare industry, as well as the rise in the demand for automated solutions in order to connect, monitor and control the complex production process, the MES providers market for the healthcare sector is likely to witness positive growth over the coming years. It is worth highlighting that, players are integrating advanced technologies, including internet of thing (IoT) and artificial intelligence (AI), in order to collect and analyze large volumes of data from various sources, as well as to produce value in the form of insights, predictions and actions.

    The financial opportunity within the manufacturing execution system providers in healthcare market has been analyzed across the following segments:

     Type of Deployment
     Cloud
     Corporate Datacenter
     Hybrid
     On Premise

     Type of End User
     Life science / Biotechnology Companies
     Medical Device Providers
     Pharmaceutical Companies
     Others

     Key Geographical Regions
     North America
     Europe
     Asia
     Middle East and North Africa
     Latin America
     Rest of the World

    The “Manufacturing Execution System Market, 2022-2035” report the following companies, which we identified to be key players in this domain:
     Andea
     Critical Manufacturing
     Dassault Systèmes
     GE Digital
     Infor
     Körber
     Rockwell Automation

    Table of Contents

    Background

    Executive Summary

    Introduction

    Market Landscape

    Key Insights

    Partnerships and Collaborations

    Company Competitiveness Analysis

    Company Profiles

    Value Creation Framework: A Strategic Guide to Address Unmet Need For Manufacturing Execution Systems

    Market Forecast

    Appendix I: Other Figures

    Appendix II: Tabulated Data

    Appendix III: List of Companies and Organizations


    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market.html

    You may also be interested in the following titles:
    Global Antibiotics Market

    Pharmaceutical Polymers / Medical Polymers Market


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #Manufacturing execution systems Market #ManufacturingexecutionsystemsMarket Size #mes#manufacturingexecutionsystems #ManufacturingExecutionSystems

    Manufacturing execution systems market Research Report by 2022, Forecast till 2035 Rising complexities related to huge data volumes being generated in the healthcare sector, along with the need for visibility, control and synchronization in production processes, has prompted players in the healthcare market to integrate manufacturing execution systems Driven by the ongoing innovation in the healthcare industry, as well as the rise in the demand for automated solutions in order to connect, monitor and control the complex production process, the MES providers market for the healthcare sector is likely to witness positive growth over the coming years. It is worth highlighting that, players are integrating advanced technologies, including internet of thing (IoT) and artificial intelligence (AI), in order to collect and analyze large volumes of data from various sources, as well as to produce value in the form of insights, predictions and actions. The financial opportunity within the manufacturing execution system providers in healthcare market has been analyzed across the following segments:  Type of Deployment  Cloud  Corporate Datacenter  Hybrid  On Premise  Type of End User  Life science / Biotechnology Companies  Medical Device Providers  Pharmaceutical Companies  Others  Key Geographical Regions  North America  Europe  Asia  Middle East and North Africa  Latin America  Rest of the World The “Manufacturing Execution System Market, 2022-2035” report the following companies, which we identified to be key players in this domain:  Andea  Critical Manufacturing  Dassault Systèmes  GE Digital  Infor  Körber  Rockwell Automation Table of Contents Background Executive Summary Introduction Market Landscape Key Insights Partnerships and Collaborations Company Competitiveness Analysis Company Profiles Value Creation Framework: A Strategic Guide to Address Unmet Need For Manufacturing Execution Systems Market Forecast Appendix I: Other Figures Appendix II: Tabulated Data Appendix III: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market.html You may also be interested in the following titles: Global Antibiotics Market Pharmaceutical Polymers / Medical Polymers Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Manufacturing execution systems Market #ManufacturingexecutionsystemsMarket Size #mes#manufacturingexecutionsystems #ManufacturingExecutionSystems
    WWW.ROOTSANALYSIS.COM
    Manufacturing execution systems Market Size, Share, Trends and Forecast (2035)
    The global manufacturing execution systems market is projected to grow from USD 3 billion in 2022 to USD 20.4 billion by 2035, exhibiting a CAGR of 16% during forecast period
    0 Comments 0 Shares
  • Bacteriophage therapeutics market Research Report by 2022, Forecast till 2035

    With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.

    One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.

    The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:
     Type of Therapeutic Area
     Infectious Diseases
     Oncological Disorders
     Other Disorders
     Distribution by Route of Administration
     Oral Route
     Rectal Route
     Intravesical Route
     Topical Route

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Latin America
     Middle East and North Africa

    The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
     Adaptive Phage Therapeutics
     ContaFect
     Eliava BioPreparations
     Micreos
     NPO Microgen
     Phagelux
     Pherecydes Pharma

    Table of Content

    1. PREFACE

    2. EXECUTIVE SUMMARY

    3. INTRODUCTION

    4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE

    5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE

    6. COMPANY AND DRUG PROFILES

    7. CLINICAL TRIAL ANALYSIS

    8. PATENT ANALYSIS

    9. PUBLICATION BENCHMARKING ANALYSIS

    10. ACADEMIC GRANTS ANALYSIS

    11. FUNDING AND INVESTMENT ANALYSIS

    12. PARTNERSHIPS AND COLLABORATIONS

    13. START-UP HEALTH INDEXING

    14. MARKET FORECAST AND OPPORTUNITY ANALYSIS

    15. CONCLUSION

    16. EXECUTIVE INSIGHTS

    17. APPENDIX I: TABULATED DATA

    18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
    For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html

    You may also be interested in the following titles:
    Pharmaceutical Polymers / Medical Polymers Market

    Gene Switch Market


    You may also like to learn what our experts are sharing in Roots educational series:
    T-cell Immunotherapies: The Future of Modern Cancer Treatments

    Monkeypox: Disease Overview, Transmission and Diagnosis


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #Bacteriophage therapeutics market #Bacteriophagetherapeuticsmarketsize #bacteriophagephage #bacteriophagetherapy



    Bacteriophage therapeutics market Research Report by 2022, Forecast till 2035 With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases. One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains. The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:  Type of Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders  Distribution by Route of Administration  Oral Route  Rectal Route  Intravesical Route  Topical Route  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:  Adaptive Phage Therapeutics  ContaFect  Eliava BioPreparations  Micreos  NPO Microgen  Phagelux  Pherecydes Pharma Table of Content 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE 5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE 6. COMPANY AND DRUG PROFILES 7. CLINICAL TRIAL ANALYSIS 8. PATENT ANALYSIS 9. PUBLICATION BENCHMARKING ANALYSIS 10. ACADEMIC GRANTS ANALYSIS 11. FUNDING AND INVESTMENT ANALYSIS 12. PARTNERSHIPS AND COLLABORATIONS 13. START-UP HEALTH INDEXING 14. MARKET FORECAST AND OPPORTUNITY ANALYSIS 15. CONCLUSION 16. EXECUTIVE INSIGHTS 17. APPENDIX I: TABULATED DATA 18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html You may also be interested in the following titles: Pharmaceutical Polymers / Medical Polymers Market Gene Switch Market You may also like to learn what our experts are sharing in Roots educational series: T-cell Immunotherapies: The Future of Modern Cancer Treatments Monkeypox: Disease Overview, Transmission and Diagnosis About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Bacteriophage therapeutics market #Bacteriophagetherapeuticsmarketsize #bacteriophagephage #bacteriophagetherapy
    WWW.ROOTSANALYSIS.COM
    Bacteriophage Therapy Market Size, Share, Trends and Forecast (2035)
    The global bacteriophage therapy market is projected to grow from USD 74 million in 2022 to USD 193 million by 2035, exhibiting a CAGR of 8% during forecast period
    0 Comments 0 Shares
  • Modular facilities Manufacturers market, Size and Share by 2035


    Modular facilities can be an effective way for drug developers and manufacturers to reduce costs, minimize delays, and expedite time-to-market, by utilizing the available infrastructure while operating in accordance with the standard GMP guidelines

    The financial opportunity within modular facilities market has been analyzed across the following segments:
     Size of Facility
     Small Plants
     Mid-sized Plants
     Large Plants
     Very Large Plants

     Type of Industry Served
     Pharmaceutical
     Biotechnology

     Type of Modular Construct
     Hybrid Skid Modular Constructs
     Plug-and-Play Modular Constructs
     Skid-Mounted Modular Constructs
     Truckable Modular Constructs
     Others Modular Constructs

     Type of Construction Component
     Process Equipment
     Base Building
     Mechanical, Electrical and Plumbing System
     Process Commodities
     Other Construction Components

     Type of Facility
     Manufacturing
     Aseptic Filling
     Research and Development
     Others

     Scale of Operation
     Clinical
     Commercial

     Type of Product
     Cell and Gene Therapies
     Vaccines
     Biosimilars
     Monoclonal Antibodies
     Advanced Pharmaceuticals
     Sterile Products
     Viral Vectors
     Other Products

     Type of Expansion
     New Facilities
     Facility Expansions
     Planned Expansions

     Type of Modular Construction
     Relocatable
     Permanent

     Type of Material
     Steel
     Wood
     Concrete

     Key Geographical Regions
     North America
     Europe
     Asia
     Middle East and North Africa (MENA)
     Rest of the world

    The Modular Facilities in the Pharmaceutical and Biotech Market, 2023-2035, report features the following companies, which we identified to be key players in this domain:
     Cytiva
     G-CON Manufacturing
     Germfree
     IPM Technologies
     KeyPlants
     ModuleCo Pharma
     NNE
     Pharmadule

    Table of Contents
    1. Preface

    2. Executive Summary

    3. Introduction

    4. Market Landscape: Modular Facility Manufacturers

    5. Market Landscape: Modular Cleanroom Providers

    6. Modular Facility Manufacturers: Company Competitiveness Analysis

    7. Company Profiles

    8. Partnerships and Collaborations

    9. Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry

    10. Facility Construction Trends in the Pharmaceutical Industry

    11. Cost, Time Optimization Framework

    12. Market Forecast

    13. Prevalent and Emerging Trends

    14. Future Growth Opportunities

    15. Conclusion

    16. Executive insights

    17. Appendix I: Tabulated data

    18. Appendix II: List of Companies and Organizations


    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/view_document/modular-manufacturing-market/178.html


    You may also be interested in the following titles:
    Cannabis Testing Market

    Decentralized Clinical Trials / Virtual Clinical Trials Market


    You may also like to learn what our experts are sharing in Roots educational series:
    mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

    Novel Cell Cytometers: Need of the Hour


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #ModularfacilitiesManufacturersMarketTrends #Modularfacilities #ManufacturersMarketGrowth #OffsiteConstruction #PrefabricatedBuildings #TemporaryBuildings
    Modular facilities Manufacturers market, Size and Share by 2035 Modular facilities can be an effective way for drug developers and manufacturers to reduce costs, minimize delays, and expedite time-to-market, by utilizing the available infrastructure while operating in accordance with the standard GMP guidelines The financial opportunity within modular facilities market has been analyzed across the following segments:  Size of Facility  Small Plants  Mid-sized Plants  Large Plants  Very Large Plants  Type of Industry Served  Pharmaceutical  Biotechnology  Type of Modular Construct  Hybrid Skid Modular Constructs  Plug-and-Play Modular Constructs  Skid-Mounted Modular Constructs  Truckable Modular Constructs  Others Modular Constructs  Type of Construction Component  Process Equipment  Base Building  Mechanical, Electrical and Plumbing System  Process Commodities  Other Construction Components  Type of Facility  Manufacturing  Aseptic Filling  Research and Development  Others  Scale of Operation  Clinical  Commercial  Type of Product  Cell and Gene Therapies  Vaccines  Biosimilars  Monoclonal Antibodies  Advanced Pharmaceuticals  Sterile Products  Viral Vectors  Other Products  Type of Expansion  New Facilities  Facility Expansions  Planned Expansions  Type of Modular Construction  Relocatable  Permanent  Type of Material  Steel  Wood  Concrete  Key Geographical Regions  North America  Europe  Asia  Middle East and North Africa (MENA)  Rest of the world The Modular Facilities in the Pharmaceutical and Biotech Market, 2023-2035, report features the following companies, which we identified to be key players in this domain:  Cytiva  G-CON Manufacturing  Germfree  IPM Technologies  KeyPlants  ModuleCo Pharma  NNE  Pharmadule Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: Modular Facility Manufacturers 5. Market Landscape: Modular Cleanroom Providers 6. Modular Facility Manufacturers: Company Competitiveness Analysis 7. Company Profiles 8. Partnerships and Collaborations 9. Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry 10. Facility Construction Trends in the Pharmaceutical Industry 11. Cost, Time Optimization Framework 12. Market Forecast 13. Prevalent and Emerging Trends 14. Future Growth Opportunities 15. Conclusion 16. Executive insights 17. Appendix I: Tabulated data 18. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/modular-manufacturing-market/178.html You may also be interested in the following titles: Cannabis Testing Market Decentralized Clinical Trials / Virtual Clinical Trials Market You may also like to learn what our experts are sharing in Roots educational series: mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Novel Cell Cytometers: Need of the Hour About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #ModularfacilitiesManufacturersMarketTrends #Modularfacilities #ManufacturersMarketGrowth #OffsiteConstruction #PrefabricatedBuildings #TemporaryBuildings
    WWW.ROOTSANALYSIS.COM
    Modular Manufacturing Market | Industry Analysis | Market Size | 2035
    Modular manufacturing facilities market, driven by over 50 companies offering cost and time optimized solution, is likely to grow at 10% CAGR
    0 Comments 0 Shares
  • Dental 3D Printing market Size, Share, Trends by 2035

    Owing to the increasing applications of the dental 3D printed products, the 3D printing technology has garnered significant attention from stakeholders in the dental industry

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Dental 3D Printing Market, 2023 – 2035”

    The study features an in-depth analysis, highlighting the capabilities of dental 3D printer developers engaged in this domain. Amongst other elements, the report features:
     A detailed assessment of the current market landscape of currently available dental 3D printers and their developers.
     A product competitiveness analysis of the dental 3D printer manufacturers, based on supplier power and product competitiveness.
     An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2018-2022 (till September).
     An in-depth analysis of the patents that have been filed / granted related to dental 3D printing, during the period 2019-2022 (till October).
     A qualitative analysis to understand the pricing strategy under an insightful bowman's strategy clock framework.
     Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in dental 3D printing domain.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
    Type of Printing Technology
    VAT Polymerization Technology
    Powder Bed Fusion Technology
    Polyjet Technology
    Metal Extrusion Technology
    Other Technologies

    Application Area
    Prosthodontics
    Orthodontics
    Dental Implants
    Other Applications

    Type of Printing Material
    Resins
    Plastics
    Metals
    Metals
    Other Material

    Key Geographical Regions
    North America
    Europe
    Asia-Pacific
    Latin America
    Middle East and North Africa
    Rest of the World

    Key companies covered in the report
     3D Systems
     Asiga
     BEGO
     Carbon
     Digital Wax Systems (DWS)
     Formlabs
     Prodways
     Rapid Shape
     SprintRay
     Stratasys


    Get more details on the Dental 3D Printing Market report https://www.rootsanalysis.com/reports/dental-3d-printing-market.html

    You may also be interested in the following titles:
    DNA Encoded Libraries
    Quantum Computing in Drug Discovery Services Market

    You may also like to learn what our experts are sharing in Roots educational series:
    mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule

    TIL Therapies: A New Paradigm in Cancer Treatment


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #Dental3DPrintingmarket #Dental3DPrintingmarketsize #Dental3dPrinterManufacturers #DentalPrinterManufacturers #Dental3DPrinterManufacturersforDentalImplants
    Dental 3D Printing market Size, Share, Trends by 2035 Owing to the increasing applications of the dental 3D printed products, the 3D printing technology has garnered significant attention from stakeholders in the dental industry Roots Analysis is pleased to announce the publication of its recent study, titled, “Dental 3D Printing Market, 2023 – 2035” The study features an in-depth analysis, highlighting the capabilities of dental 3D printer developers engaged in this domain. Amongst other elements, the report features:  A detailed assessment of the current market landscape of currently available dental 3D printers and their developers.  A product competitiveness analysis of the dental 3D printer manufacturers, based on supplier power and product competitiveness.  An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2018-2022 (till September).  An in-depth analysis of the patents that have been filed / granted related to dental 3D printing, during the period 2019-2022 (till October).  A qualitative analysis to understand the pricing strategy under an insightful bowman's strategy clock framework.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in dental 3D printing domain.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below): Type of Printing Technology VAT Polymerization Technology Powder Bed Fusion Technology Polyjet Technology Metal Extrusion Technology Other Technologies Application Area Prosthodontics Orthodontics Dental Implants Other Applications Type of Printing Material Resins Plastics Metals Metals Other Material Key Geographical Regions North America Europe Asia-Pacific Latin America Middle East and North Africa Rest of the World Key companies covered in the report  3D Systems  Asiga  BEGO  Carbon  Digital Wax Systems (DWS)  Formlabs  Prodways  Rapid Shape  SprintRay  Stratasys Get more details on the Dental 3D Printing Market report https://www.rootsanalysis.com/reports/dental-3d-printing-market.html You may also be interested in the following titles: DNA Encoded Libraries Quantum Computing in Drug Discovery Services Market You may also like to learn what our experts are sharing in Roots educational series: mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule TIL Therapies: A New Paradigm in Cancer Treatment About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Dental3DPrintingmarket #Dental3DPrintingmarketsize #Dental3dPrinterManufacturers #DentalPrinterManufacturers #Dental3DPrinterManufacturersforDentalImplants
    WWW.ROOTSANALYSIS.COM
    Dental 3D Printing Market | Industry Analysis | Market Size | 2035
    Dental 3D printing market, driven by over 230 dental 3D printers being development or available in the market, is expected grow at over 14% CAGR
    0 Comments 0 Shares
  • DNA and Gene Cloning Services market Size, Share, Trends by 2035

    DNA and gene cloning have diverse applications, including modern biotechnological, medicinal, and several diagnostic ones cccas DNA and gene cloning has proven to be beneficial for research and development in the biopharmaceutical and healthcare industries.

    Presently, a number of players having dedicated facilities, cutting-edge machinery, and production lines, are offering DNA and gene cloning services to the various stakeholders in this domain.

    The rapidly growing financial opportunity within the DNA and gene cloning services market has been analyzed across the following segments:
     Type of Service Offered
     Gene Synthesis
     Custom Cloning
     Sub-cloning
     Others
     Type of Gene
     Standard Gene
     Complex Gene
     Others
     Company Size
     Small
     Mid-sized
     Large
     End-User Industry
     Academic and R&D
     Pharmaceutical and Biotechnology Companies
     Other End Users
     Key Geographical Region
     North America
     Europe
     Asia-Pacific
     Latin America
     MENA

    The DNA and Gene Cloning Services Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:
     Aragen
     Bio-Techne
     Charles River Laboratories
     Curia
     Eurofins
     GenScript
     Integrated DNA Technologies
     MedGenome
     Sino Biological
     Syngene
     Twist Bioscience

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Market Landscape: DNA Cloning and Gene Cloning Service Providers

    5. Benchmark Analysis

    6. Company Profiles

    7. Patent Analysis

    8. Publication Analysis

    9. Global Event Analysis

    10. Market Forecast

    11. Case Study: DNA and Gene Cloning Kits and Reagents

    12. Concluding Remarks

    13. Executive Insights

    14. Appendix 1: Tabulated Data

    15. Appendix 2: List of Companies and Organizations

    Get more details on the DNA and Gene Cloning Services Market report https://www.rootsanalysis.com/reports/dna-and-gene-cloning-market.html

    You may also be interested in the following titles:
    Lab Automation Market

    Cannabis Testing Market


    You may also like to learn what our experts are sharing in Roots educational series:
    Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?

    Exploring How Artificial Intelligence Is Transforming Digital Pathology


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #DNA and Gene Cloning Services Market #DNAandGeneCloningServicesMarketGrowth #DNAandGeneCloningServices #GeneCloningMarket #GeneCloningServices

    DNA and Gene Cloning Services market Size, Share, Trends by 2035 DNA and gene cloning have diverse applications, including modern biotechnological, medicinal, and several diagnostic ones cccas DNA and gene cloning has proven to be beneficial for research and development in the biopharmaceutical and healthcare industries. Presently, a number of players having dedicated facilities, cutting-edge machinery, and production lines, are offering DNA and gene cloning services to the various stakeholders in this domain. The rapidly growing financial opportunity within the DNA and gene cloning services market has been analyzed across the following segments:  Type of Service Offered  Gene Synthesis  Custom Cloning  Sub-cloning  Others  Type of Gene  Standard Gene  Complex Gene  Others  Company Size  Small  Mid-sized  Large  End-User Industry  Academic and R&D  Pharmaceutical and Biotechnology Companies  Other End Users  Key Geographical Region  North America  Europe  Asia-Pacific  Latin America  MENA The DNA and Gene Cloning Services Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:  Aragen  Bio-Techne  Charles River Laboratories  Curia  Eurofins  GenScript  Integrated DNA Technologies  MedGenome  Sino Biological  Syngene  Twist Bioscience Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: DNA Cloning and Gene Cloning Service Providers 5. Benchmark Analysis 6. Company Profiles 7. Patent Analysis 8. Publication Analysis 9. Global Event Analysis 10. Market Forecast 11. Case Study: DNA and Gene Cloning Kits and Reagents 12. Concluding Remarks 13. Executive Insights 14. Appendix 1: Tabulated Data 15. Appendix 2: List of Companies and Organizations Get more details on the DNA and Gene Cloning Services Market report https://www.rootsanalysis.com/reports/dna-and-gene-cloning-market.html You may also be interested in the following titles: Lab Automation Market Cannabis Testing Market You may also like to learn what our experts are sharing in Roots educational series: Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? Exploring How Artificial Intelligence Is Transforming Digital Pathology About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #DNA and Gene Cloning Services Market #DNAandGeneCloningServicesMarketGrowth #DNAandGeneCloningServices #GeneCloningMarket #GeneCloningServices
    WWW.ROOTSANALYSIS.COM
    DNA Cloning and Gene Cloning Services | Industry Analysis | Market Size | 2035
    DNA Cloning and Gene Cloning Services Market expected to grow rapidly at a CGAR of more than 15%, representative of rapid future market opportunity till 2035
    0 Comments 0 Shares
  • Latest news on TCR Therapy market Research Report by 2035


    The new market report titled ‘TCR Therapy Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the TCR Therapy Market.

    The report will help readers stay updated with the latest market trends and maintain their competitive outlooks in the modern-day fast-paced business environment. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, product landscape, key marketing strategies, technological progress, as well as the emerging market trends and opportunities. The TCR-based Therapy Market is anticipated to expand significantly. However, the latest report is mainly intended for readers interested in this specific business space and is available in the forms of PDF and spreadsheet.

    TCR Therapy Market Characterization:
    Market Scope and Market Size:
    The TCR Therapy market is broadly segmented on the basis of product type and application. The segmental growth helps the reader get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the TCR Therapy market in terms of market size & volume and significant information pertaining to product bifurcation and application overview. An analysis of the investments that have been made into companies that have proprietary TCR-based products / technologies.


    Key Market Contenders:
    This particular section of the report covers all the necessary details of the renowned market players operating in the TCR Therapy market. The report goes on to elucidate various marketing strategies employed by companies across this industry. Information on the shareholdings of these players in the global market has also been included in this report. Moreover, the document presents a detailed account of the market size based on geographical segmentation. It also covers the product portfolio, their application landscape, and sales and revenue predictions of the regional fragments of the global market.

    The section of this report focusing on the competitive terrain of the TCR Therapy market endows the reader with every significant detail and information about the leading competitors on the market. The report provides an exhaustive study and accurate statistics on revenue (on both global and regional levels) related to the prevalent competition in the market. The report offers additional details on this fundamental market segment, including major businesses, company description, total revenue & sales, recent developments, latest product launches, and revenue accumulated by these players over the forecast period.

    Main chapters covered in this report:
    Part 01: Market Overview
    Part 02: Market Size, by regions
    Part 03: Market Revenue, by countries
    Part 04: Market Competition, by key players
    Part 05: Company Profiles

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/reports/tcr-based-therapies-market.html

    You may also be interested in the following titles:
    Women’s Digital Health Market

    Modular Manufacturing Facilities Market


    You may also like to learn what our experts are sharing in Roots educational series:
    Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin

    Introduction To Exosome Therapeutics


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    +44 (122) 391 1091
    Ben.johnson@rootsanalysis.com

    #TCRTherapyMarketSize #TCRTherapyMarketTrends #TCRimmunotherapies #TCRbasedproducts #TCRTherapy
    Latest news on TCR Therapy market Research Report by 2035 The new market report titled ‘TCR Therapy Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the TCR Therapy Market. The report will help readers stay updated with the latest market trends and maintain their competitive outlooks in the modern-day fast-paced business environment. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, product landscape, key marketing strategies, technological progress, as well as the emerging market trends and opportunities. The TCR-based Therapy Market is anticipated to expand significantly. However, the latest report is mainly intended for readers interested in this specific business space and is available in the forms of PDF and spreadsheet. TCR Therapy Market Characterization: Market Scope and Market Size: The TCR Therapy market is broadly segmented on the basis of product type and application. The segmental growth helps the reader get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the TCR Therapy market in terms of market size & volume and significant information pertaining to product bifurcation and application overview. An analysis of the investments that have been made into companies that have proprietary TCR-based products / technologies. Key Market Contenders: This particular section of the report covers all the necessary details of the renowned market players operating in the TCR Therapy market. The report goes on to elucidate various marketing strategies employed by companies across this industry. Information on the shareholdings of these players in the global market has also been included in this report. Moreover, the document presents a detailed account of the market size based on geographical segmentation. It also covers the product portfolio, their application landscape, and sales and revenue predictions of the regional fragments of the global market. The section of this report focusing on the competitive terrain of the TCR Therapy market endows the reader with every significant detail and information about the leading competitors on the market. The report provides an exhaustive study and accurate statistics on revenue (on both global and regional levels) related to the prevalent competition in the market. The report offers additional details on this fundamental market segment, including major businesses, company description, total revenue & sales, recent developments, latest product launches, and revenue accumulated by these players over the forecast period. Main chapters covered in this report: Part 01: Market Overview Part 02: Market Size, by regions Part 03: Market Revenue, by countries Part 04: Market Competition, by key players Part 05: Company Profiles To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/tcr-based-therapies-market.html You may also be interested in the following titles: Women’s Digital Health Market Modular Manufacturing Facilities Market You may also like to learn what our experts are sharing in Roots educational series: Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin Introduction To Exosome Therapeutics About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com #TCRTherapyMarketSize #TCRTherapyMarketTrends #TCRimmunotherapies #TCRbasedproducts #TCRTherapy
    WWW.ROOTSANALYSIS.COM
    TCR Therapies Market | Industry Analysis | Market Size | 2035
    TCR therapies market, driven by over 190 TCR therapies in pipeline and USD 11 billion investment, is anticipated to grow at over 50% CAGR in the coming decade
    0 Comments 0 Shares
  • Latest news on non-viral drug delivery system market Research Report by 2035

    The new market report titled ‘Non-Viral Drug Delivery Systems Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the Non-Viral Drug Delivery Systems Market.

    The report will help readers stay updated with the latest market trends and maintain their competitive outlooks in the modern-day fast-paced business environment. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, product landscape, key marketing strategies, technological progress, as well as the emerging market trends and opportunities. The Non-Viral Drug Delivery Systems Market is anticipated to expand significantly. However, the latest report is mainly intended for readers interested in this specific business space and is available in the forms of PDF and spreadsheet.

    Non-Viral Drug Delivery Systems Market Characterization:

    Market Scope and Market Size:
    The Non-Viral Drug Delivery Systems market is broadly segmented on the basis of product type and application. The segmental growth helps the reader get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the Non-Viral Drug Delivery Systems market in terms of market size & volume and significant information pertaining to product bifurcation and application overview.

    Key Market Contenders:
    This particular section of the report covers all the necessary details of the renowned market players operating in the Non-Viral Drug Delivery Systems market. The report goes on to elucidate various marketing strategies employed by companies across this industry. Information on the shareholdings of these players in the global market has also been included in this report. Moreover, the document presents a detailed account of the market size based on geographical segmentation. It also covers the product portfolio, their application landscape, and sales and revenue predictions of the regional fragments of the global market.

    The section of this report focusing on the competitive terrain of the Intracellular Drug Delivery Systems market endows the reader with every significant detail and information about the leading competitors on the market. The report provides an exhaustive study and accurate statistics on revenue (on both global and regional levels) related to the prevalent competition in the market. The report offers additional details on this fundamental market segment, including major businesses, company description, total revenue & sales, recent developments, latest product launches, and revenue accumulated by these players over the forecast period.

    Main chapters covered in this report:
    Part 01: Market Overview
    Part 02: Market Size, by regions
    Part 03: Market Revenue, by countries
    Part 04: Market Competition, by key players
    Part 05: Company Profiles

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html

    You may also be interested in the following titles:
    Lab Automation Market

    Cannabis Testing Market


    You may also like to learn what our experts are sharing in Roots educational series:
    Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities

    Digital Therapies: The “Digital Pills” of current generation


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    +44 (122) 391 1091
    Ben.johnson@rootsanalysis.com

    #nonviraldrugdeliverysystemmarketTrends #nonviraldrugdeliverysystemmarketGrowth #intracellulardrugdeliverytechnologies #Intracellularbiologics #nonviralRNAdrugdelivery
    Latest news on non-viral drug delivery system market Research Report by 2035 The new market report titled ‘Non-Viral Drug Delivery Systems Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the Non-Viral Drug Delivery Systems Market. The report will help readers stay updated with the latest market trends and maintain their competitive outlooks in the modern-day fast-paced business environment. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, product landscape, key marketing strategies, technological progress, as well as the emerging market trends and opportunities. The Non-Viral Drug Delivery Systems Market is anticipated to expand significantly. However, the latest report is mainly intended for readers interested in this specific business space and is available in the forms of PDF and spreadsheet. Non-Viral Drug Delivery Systems Market Characterization: Market Scope and Market Size: The Non-Viral Drug Delivery Systems market is broadly segmented on the basis of product type and application. The segmental growth helps the reader get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the Non-Viral Drug Delivery Systems market in terms of market size & volume and significant information pertaining to product bifurcation and application overview. Key Market Contenders: This particular section of the report covers all the necessary details of the renowned market players operating in the Non-Viral Drug Delivery Systems market. The report goes on to elucidate various marketing strategies employed by companies across this industry. Information on the shareholdings of these players in the global market has also been included in this report. Moreover, the document presents a detailed account of the market size based on geographical segmentation. It also covers the product portfolio, their application landscape, and sales and revenue predictions of the regional fragments of the global market. The section of this report focusing on the competitive terrain of the Intracellular Drug Delivery Systems market endows the reader with every significant detail and information about the leading competitors on the market. The report provides an exhaustive study and accurate statistics on revenue (on both global and regional levels) related to the prevalent competition in the market. The report offers additional details on this fundamental market segment, including major businesses, company description, total revenue & sales, recent developments, latest product launches, and revenue accumulated by these players over the forecast period. Main chapters covered in this report: Part 01: Market Overview Part 02: Market Size, by regions Part 03: Market Revenue, by countries Part 04: Market Competition, by key players Part 05: Company Profiles To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html You may also be interested in the following titles: Lab Automation Market Cannabis Testing Market You may also like to learn what our experts are sharing in Roots educational series: Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities Digital Therapies: The “Digital Pills” of current generation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com #nonviraldrugdeliverysystemmarketTrends #nonviraldrugdeliverysystemmarketGrowth #intracellulardrugdeliverytechnologies #Intracellularbiologics #nonviralRNAdrugdelivery
    WWW.ROOTSANALYSIS.COM
    Intracellular Drug Delivery Systems Market | Industry Analysis | Market Size | 2035
    Driven by growing demand for effective drug products, the non-viral / intracellular drug delivery technologies market is likely to grow at 13.8% CAGR, till 2035
    0 Comments 0 Shares
  • mRNA Synthesis and Manufacturing Services market Analysis and Trends by 2022-2035
    Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers

    Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022–2035”

    The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes

     A general overview of mRNA, highlighting details on its structure, the evolution of mRNA vaccines, manufacturing processes and commonly outsourced manufacturing operations.
     A detailed assessment of the overall market landscape of the companies offering mRNA custom synthesis services.
     A detailed competitiveness analysis of mRNA custom synthesis service providers.
     A comprehensive assessment of the overall market landscape of mRNA contract manufacturing service providers, based on several relevant parameters.
     An in-depth company competitiveness analysis of mRNA contract manufacturing service providers based in North America, Europe and Asia-Pacific.
     A detailed overview of the current market landscape of kits available for synthesis of research grade mRNA.
     A detailed product competitiveness analysis of the mRNA synthesis kits.
     Elaborate profiles of key players engaged in the synthesis and manufacturing of mRNA (shortlisted based on strength of service portfolio).
     Detailed profiles of the key mRNA synthesis kit providers (shortlisted based on strength of product portfolio).
     A detailed assessment of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines.
     An insight analysis of the recent partnerships inked between stakeholders engaged in this domain from 2014-2022
     An in-depth analysis of over 35 mRNA-based therapeutics / vaccines developers that are likely to partner with mRNA contract manufacturing service providers.
     A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021)
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

     Type of Product
     Drug substances (APIs)
     Drug products (FDFs)

     Application Area
     mRNA-based vaccines
     mRNA-based therapeutics

     Therapeutic Area
     Infectious diseases
     Oncological disorders
     Other diseases

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Latin America
     Middle East and North Africa
     Rest of the World

    Key companies covered in the report.
     Aldevron
     APExBIO
     Biomay
     bioSYNTHESIS
     CELLSCRIPT
     eTheRNA
     Eurogentec
     Jena Biosciences
     New England Biolabs
     Thermo Fisher Scientific
     TriLink BioTechnologies

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html

    You may also be interested in the following titles:
    Cannabis Testing Market

    Decentralized Clinical Trials / Virtual Clinical Trials Market


    You may also like to learn what our experts are sharing in Roots educational series:
    Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders

    4D Bioprinting Market: Key Trends


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #mRNASynthesisandManufacturingServicesMarket #mRNASynthesisandManufacturingServicesMarketSize #mRNAsynthesisservices #mRNAsynthesisandmanufacturingservices #mRNAbasedproducts
    mRNA Synthesis and Manufacturing Services market Analysis and Trends by 2022-2035 Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022–2035” The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes  A general overview of mRNA, highlighting details on its structure, the evolution of mRNA vaccines, manufacturing processes and commonly outsourced manufacturing operations.  A detailed assessment of the overall market landscape of the companies offering mRNA custom synthesis services.  A detailed competitiveness analysis of mRNA custom synthesis service providers.  A comprehensive assessment of the overall market landscape of mRNA contract manufacturing service providers, based on several relevant parameters.  An in-depth company competitiveness analysis of mRNA contract manufacturing service providers based in North America, Europe and Asia-Pacific.  A detailed overview of the current market landscape of kits available for synthesis of research grade mRNA.  A detailed product competitiveness analysis of the mRNA synthesis kits.  Elaborate profiles of key players engaged in the synthesis and manufacturing of mRNA (shortlisted based on strength of service portfolio).  Detailed profiles of the key mRNA synthesis kit providers (shortlisted based on strength of product portfolio).  A detailed assessment of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines.  An insight analysis of the recent partnerships inked between stakeholders engaged in this domain from 2014-2022  An in-depth analysis of over 35 mRNA-based therapeutics / vaccines developers that are likely to partner with mRNA contract manufacturing service providers.  A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021)  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Product  Drug substances (APIs)  Drug products (FDFs)  Application Area  mRNA-based vaccines  mRNA-based therapeutics  Therapeutic Area  Infectious diseases  Oncological disorders  Other diseases  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World Key companies covered in the report.  Aldevron  APExBIO  Biomay  bioSYNTHESIS  CELLSCRIPT  eTheRNA  Eurogentec  Jena Biosciences  New England Biolabs  Thermo Fisher Scientific  TriLink BioTechnologies To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html You may also be interested in the following titles: Cannabis Testing Market Decentralized Clinical Trials / Virtual Clinical Trials Market You may also like to learn what our experts are sharing in Roots educational series: Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders 4D Bioprinting Market: Key Trends About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mRNASynthesisandManufacturingServicesMarket #mRNASynthesisandManufacturingServicesMarketSize #mRNAsynthesisservices #mRNAsynthesisandmanufacturingservices #mRNAbasedproducts
    WWW.ROOTSANALYSIS.COM
    mRNA Synthesis and mRNA Manufacturing | Market Size | Industry Analysis | 2035
    mRNA synthesis and mRNA manufacturing market, driven by 70+ mRNA manufacturers, is anticipated to gain traction for non-covid mRNA therapeutics in the coming decade
    0 Comments 0 Shares
  • CRISPR Technologies: Intellectual Property Landscape market Research Report by 2022, Forecast till 2035

    The new market report titled ‘CRISPR Technologies: Intellectual Property Landscape,’ published by Roots Analysis features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various types of CRISPR Technologies.

    The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing trend in this domain.

    To view more details on this report, click on the link:
    https://www.rootsanalysis.com/reports/crispr-technologies-ip-landscape.html

    Main Chapters in the CRISPR Technologies Intellectual Property Landscape Report

     Overall Intellectual Property Landscape
    An analytical perspective of the various patents and affiliated IP documents that have been published related to CRISPR Technologies, since 2000. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent R&D trends within this domain.

     Popular / Relevant Prior Art Search Expressions
    An examination of IP literature, shortlisting key words and phrases used to describe CRISPR Technologies. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms and other related trends.

     Patent Valuation Analysis
    Competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters of the patent application.

     Patentability and Freedom to Operate
    A systematic and Roots Proprietary approach to identify relevant areas of innovation by analyzing published IP documents, by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP.

     Analysis of Patent Applications and Granted CRISPR Technologies Patents
    A detailed summary of the various patent applications and granted patents across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of type of innovation and the innovation related to CRISPR Technologies, thereby offering the means to identify active arenas of research and assess innovation-specific IP filing trends.

     Pockets of Innovation and White Spaces
    An insightful analysis of the various CPC codes used in published IP literature and their affiliated families, offering the means to identify historical and existing pockets of innovation, the analysis also features a discussion on prevalent white spaces.

     Claim Analysis
    One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent, type of claim and other key elements of a claim.

    Key Companies Profiled

    • 10x Genomics
    • 22nd Century Group
    • 64x Bio
    • Aadigen
    • Aarhus University

    You may also be interested in the following titles:
    Quantum Computing in Drug Discovery Services Market

    Viral Clearance and Viral Testing Services Market


    You may also like to learn what our experts are sharing in Roots educational series:
    Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?

    Medical Device Coatings and Modification Technologies

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #CRISPRTechnologiesMarket #CRISPRPatents #CRISPRIP #CRISPRTechnologyPatent #CRISPR





    CRISPR Technologies: Intellectual Property Landscape market Research Report by 2022, Forecast till 2035 The new market report titled ‘CRISPR Technologies: Intellectual Property Landscape,’ published by Roots Analysis features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various types of CRISPR Technologies. The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing trend in this domain. To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/crispr-technologies-ip-landscape.html Main Chapters in the CRISPR Technologies Intellectual Property Landscape Report  Overall Intellectual Property Landscape An analytical perspective of the various patents and affiliated IP documents that have been published related to CRISPR Technologies, since 2000. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent R&D trends within this domain.  Popular / Relevant Prior Art Search Expressions An examination of IP literature, shortlisting key words and phrases used to describe CRISPR Technologies. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms and other related trends.  Patent Valuation Analysis Competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters of the patent application.  Patentability and Freedom to Operate A systematic and Roots Proprietary approach to identify relevant areas of innovation by analyzing published IP documents, by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP.  Analysis of Patent Applications and Granted CRISPR Technologies Patents A detailed summary of the various patent applications and granted patents across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of type of innovation and the innovation related to CRISPR Technologies, thereby offering the means to identify active arenas of research and assess innovation-specific IP filing trends.  Pockets of Innovation and White Spaces An insightful analysis of the various CPC codes used in published IP literature and their affiliated families, offering the means to identify historical and existing pockets of innovation, the analysis also features a discussion on prevalent white spaces.  Claim Analysis One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent, type of claim and other key elements of a claim. Key Companies Profiled • 10x Genomics • 22nd Century Group • 64x Bio • Aadigen • Aarhus University You may also be interested in the following titles: Quantum Computing in Drug Discovery Services Market Viral Clearance and Viral Testing Services Market You may also like to learn what our experts are sharing in Roots educational series: Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market? Medical Device Coatings and Modification Technologies About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CRISPRTechnologiesMarket #CRISPRPatents #CRISPRIP #CRISPRTechnologyPatent #CRISPR
    WWW.ROOTSANALYSIS.COM
    CRISPR Technologies: Intellectual Property Landscape
    CRISPR Technologies: Intellectual Property Landscape ; with a focus on current market landscape and future growth opportunities
    0 Comments 0 Shares
More Stories
G-8F6Y62QLZ0